Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014-2018).
Vaccines (Basel)
; 8(3)2020 Aug 22.
Article
en En
| MEDLINE
| ID: mdl-32842669
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Vaccines (Basel)
Año:
2020
Tipo del documento:
Article
País de afiliación:
Italia